Moffitt Study Reveals Novel Mechanism Behind Immunotherapy Resistance
In a groundbreaking international collaboration, researchers from Moffitt Cancer Center, the Karolinska Institutet, and the University of Texas MD Anderson ...
Tag: immune checkpoint inhibitors in oncology
4-Year Results: Tislelizumab Plus Chemo for Esophageal Cancer
In a groundbreaking development within the arena of oncology, new data emerging from the phase 2 TD-NICE clinical trial reveals ...
Immunotherapy Plus Chemoradiotherapy Boosts Small-Cell Lung Cancer
Immunotherapy Concurrently Administered with Chemoradiotherapy Shows Promise in Limited-Stage Small-Cell Lung Cancer Limited-stage small-cell lung cancer (LS-SCLC) has long posed ...
PD-(L)1 Inhibitors and Anlotinib Boost SCLC Therapy
In the relentless battle against extensive-stage small cell lung cancer (ES-SCLC), medical researchers are continuously seeking therapeutic strategies that offer ...
Rechallenging Immune-Checkpoint Inhibitors in Advanced Lung Cancer
In the relentless battle against lung cancer, a formidable adversary that continues to claim more lives worldwide than any other ...
Inflammation Predicts Immunotherapy Success in Lung Cancer
The Prognostic Power of Systemic Inflammation in Immunotherapy for Non-Small Cell Lung Cancer: New Meta-Analytical Insights Lung cancer remains a ...
Pre-Surgical Immunotherapy Boosts Lung Cancer Survival: Findings from Global Trial Led by Irish Cancer Expert
A landmark advancement in lung cancer treatment has emerged from a recently published phase 3 clinical trial in the prestigious ...
Ivonescimab Sheds Light on NSCLC Immuno-Angiogenesis
The landscape of non-small cell lung cancer (NSCLC) treatment has undergone a radical transformation in recent years, driven by advances ...
Emerging Advances and Future Prospects in Anal Cancer
The landscape of anal squamous cell carcinoma (ASCC), a rare yet increasingly prevalent malignancy, is undergoing a profound transformation fueled ...
Tifcemalimab and Toripalimab Trial in Lymphoma
In a groundbreaking advancement in oncology, a recent Phase I clinical trial has explored the therapeutic potential of tifcemalimab, both ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!